Nexcella announces poster presentation at the European Society for Blood and Marrow Transplantation 49th Annual Meeting
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will…
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will…
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will…
— Children aged 5 to 17 with autism are now eligible to enroll in the…
Clinical collaboration with BeiGene announced on April 3, 2023 to evaluate the safety and efficacy…
— Children aged 5 to 17 with autism are now eligible to enroll in the…
Clinical collaboration with BeiGene announced on April 3, 2023 to evaluate the safety and efficacy…
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will…
Favorable feedback following meeting with the U.S. Food and Drug Administration (FDA) allows for planned…
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will…
Favorable feedback following meeting with the U.S. Food and Drug Administration (FDA) allows for planned…
— Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated…
— Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated…
BERLIN and INDIANAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) — Eckert & Ziegler (ISIN DE0005659700, TecDAX)…
BERLIN and INDIANAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) — Eckert & Ziegler (ISIN DE0005659700, TecDAX)…
Feasibility and safety demonstrated in patients with advanced heart failure Safe maximal dose for continuation…
Feasibility and safety demonstrated in patients with advanced heart failure Safe maximal dose for continuation…
Companies seek compensation for Pfizer’s and BioNTech’s unlicensed use of patented technologies in COVID-19 mRNA-LNP…
SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Nephros, Inc. (Nasdaq:…
Companies seek compensation for Pfizer’s and BioNTech’s unlicensed use of patented technologies in COVID-19 mRNA-LNP…
CAMBRIDGE, Mass., April 04, 2023 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the…